Key Financial Data Of Reporting Company

Riken Vitamin Co., Ltd. - Filing #7294167

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
47,149,000,000 JPY
91,484,000,000 JPY
44,613,000,000 JPY
Ordinary profit (loss)
4,786,000,000 JPY
10,296,000,000 JPY
5,220,000,000 JPY
Net assets
78,130,000,000 JPY
76,643,000,000 JPY
77,365,000,000 JPY
Total assets
115,044,000,000 JPY
118,776,000,000 JPY
113,913,000,000 JPY
Basic earnings (loss) per share
107.22
268.44
111.74
Diluted earnings per share
Equity-to-asset ratio
0.679 xbrli:pure
0.645 xbrli:pure
0.679 xbrli:pure
Net cash provided by (used in) operating activities
2,836,000,000 JPY
10,451,000,000 JPY
4,649,000,000 JPY
Net cash provided by (used in) investing activities
-828,000,000 JPY
-554,000,000 JPY
-729,000,000 JPY
Net cash provided by (used in) financing activities
-2,984,000,000 JPY
-7,084,000,000 JPY
-2,673,000,000 JPY
Cash and cash equivalents
19,632,000,000 JPY
20,141,000,000 JPY
18,490,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.